Novartis AG is 78.1x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($282.64 B vs $3.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRNX | NVS |
|---|---|---|
| Market cap | $3.62 B | $282.64 B |
| US-listed rank | #1659 | #47 |
| Revenue (latest FY) | $7.70M | - |
| Net income (latest FY) | -$465.30M | - |
| Net margin | -6046.0% | - |
| SEC filings | 670 | 947 |
Novartis AG is 78.1x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($282.64 B vs $3.62 B).
Full pages: Crinetics Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.